Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Phillip H. Lam"'
Autor:
Charles O. Faselis, Gregg C. Fonarow, Farooq H. Sheikh, Shalini D. Allam, Prakash Deedwania, Cherinne Arundel, Ali Ahmed, Wilbert S. Aronow, Poonam Bhyan, Venkatesh K. Raman, Phillip H. Lam, Samir S. Patel, Ioannis Kanonidis, Richard M. Allman, Apostolos Tsimploulis
Publikováno v:
The American Journal of Medicine. 135:737-744
Background In patients with heart failure with reduced ejection fraction (HFrEF) and hypertension, systolic blood pressure is recommended to be maintained below 130 mmHg, although this has not been shown to be associated with improved outcomes. We ex
Autor:
Gerasimos Filippatos, Brandon George, Kalliopi Keramida, Charity J. Morgan, Gaurav Choudhary, Neha Gupta, Ami E. Iskandrian, Wen-Chih Wu, Prakash Deedwania, Ali Ahmed, Gregg C. Fonarow, John G.F. Cleland, Charles Faselis, Phillip H. Lam
Publikováno v:
Journal of Cardiac Failure. 28:65-70
Background A low right ventricular ejection fraction (RVEF) is a marker of poor outcomes in patients with heart failure with reduced ejection fraction (HFrEF). Beta-blockers improve outcomes in HFrEF, but whether this effect is modified by RVEF is un
Autor:
Michel White, Chakradhari Inampudi, Prakash Deedwania, Wilbert S. Aronow, Wen-Chih Wu, Javed Butler, Richard M. Allman, Charity J. Morgan, Gregg C. Fonarow, Cherinne Arundel, Ali Ahmed, Phillip H. Lam, Daniel J. Dooley, Sumanth D. Prabhu, Thomas E. Love, Markus S. Anker, Marc R. Blackman
Publikováno v:
International journal of cardiology. 227
Therapy with evidence-based heart failure (HF) medications has been shown to be associated with lower risk of 30-day all-cause readmission in patients with HF and reduced ejection fraction (HFrEF).We examined the association of aldosterone antagonist
Autor:
Stefan Anker, Bertram Pitt, Marc R. Blackman, Cherinne Arundel, Gregg Fonarow, Ali Ahmed, Essraa Bayoumi, Gerasimos Filippatos, Wilbert Aronow, Prakash Deedwania Md, Jonathan Segal, Spyridon Deftereos, Michel White, C Morgan, Phillip H. Lam, Javed Butler, Daniel J. Dooley
Publikováno v:
Journal of the American College of Cardiology. 69:914
Background: Randomized controlled trials have established the efficacy of aldosterone antagonists in patients with heart failure and reduced ejection fraction (HFrEF). However, there is limited evidence of their clinical effectiveness in real-world e